methylphenidate has been researched along with Clerambault Syndrome in 18 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 76-year-old male with poststroke depression, seizure disorder, and global aphasia improved markedly when treated with methylphenidate." | 7.69 | Methylphenidate treatment of poststroke depression in a patient with global aphasia. ( Chaudhary, P; Masand, P, 1994) |
| "Methylphenidate or dextroamphetamine was used to treat 17 of 32 patients with AIDS-related complex who were referred for neuropsychiatric evaluation of symptoms representative of cognitive and/or affective dysfunction." | 5.06 | Psychostimulant response in AIDS-related complex patients. ( Fernandez, F; Holmes, VF; Levy, JK, 1989) |
| "A 76-year-old male with poststroke depression, seizure disorder, and global aphasia improved markedly when treated with methylphenidate." | 3.69 | Methylphenidate treatment of poststroke depression in a patient with global aphasia. ( Chaudhary, P; Masand, P, 1994) |
| "Hospital charts were reviewed for 66 medical and surgical patients who received dextroamphetamine or methylphenidate to treat a depressive disorder." | 3.67 | Psychostimulant treatment of depressive disorders secondary to medical illness. ( Cassem, NH; Murray, GB; Tesar, GE; Woods, SW, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geladé, K | 1 |
| Bink, M | 1 |
| Janssen, TW | 1 |
| van Mourik, R | 1 |
| Maras, A | 1 |
| Oosterlaan, J | 1 |
| Morice, E | 1 |
| Billard, JM | 1 |
| Denis, C | 1 |
| Mathieu, F | 1 |
| Betancur, C | 1 |
| Epelbaum, J | 1 |
| Giros, B | 1 |
| Nosten-Bertrand, M | 1 |
| Hales, RE | 1 |
| Hershey, SC | 1 |
| Kaufmann, MW | 1 |
| Cassem, NH | 2 |
| Murray, GB | 2 |
| Jenike, M | 1 |
| Weinstein, GS | 1 |
| Wells, CE | 1 |
| Masand, P | 1 |
| Chaudhary, P | 1 |
| Wheeler, GA | 1 |
| Young, SA | 1 |
| Elia, J | 1 |
| Gulotta, C | 1 |
| Rose, SR | 1 |
| Marin, G | 1 |
| Rapoport, JL | 1 |
| Watanabe, MD | 1 |
| Martin, EM | 1 |
| DeLeon, OA | 1 |
| Gaviria, M | 1 |
| Pavel, DG | 1 |
| Trepashko, DW | 1 |
| Eggers, C | 1 |
| Elmore, JL | 1 |
| Sugerman, AA | 1 |
| Stiebel, V | 1 |
| Kemp, K | 1 |
| Holmes, VF | 2 |
| Fernandez, F | 2 |
| Levy, JK | 2 |
| Adams, F | 1 |
| Neidhart, M | 1 |
| Mansell, PW | 1 |
| Kløve, H | 1 |
| Woods, SW | 1 |
| Tesar, GE | 1 |
| Palatucci, DM | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment Study for Frontotemporal Dementia[NCT00088751] | 20 participants | Observational | 2004-07-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for methylphenidate and Clerambault Syndrome
| Article | Year |
|---|---|
Psychopharmacologic issues in the diagnosis and treatment of organic mental disorders.
Topics: Adrenal Cortex Hormones; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Delirium; Dementia; | 1984 |
[Psychotropic drug therapy in children].
Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; | 1977 |
3 trials available for methylphenidate and Clerambault Syndrome
| Article | Year |
|---|---|
An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula | 2017 |
Thyroid function and attention-deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Double-Blind Method; Euthyr | 1994 |
Psychostimulant response in AIDS-related complex patients.
Topics: AIDS-Related Complex; Clinical Trials as Topic; Depressive Disorder; Dextroamphetamine; Humans; Male | 1989 |
13 other studies available for methylphenidate and Clerambault Syndrome
| Article | Year |
|---|---|
Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia.
Topics: Animals; Brain Diseases, Metabolic; Cognition Disorders; Disease Models, Animal; Dopamine; Dopamine | 2007 |
Use of psychostimulants in medically ill patients with neurological disease and major depression.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Dextroamphetamin | 1984 |
Case studies in neuropsychiatry: post-traumatic psychiatric dysfunction--diagnosis and treatment.
Topics: Adult; Brain Injuries; Humans; Male; Methylphenidate; Neurocognitive Disorders; Substance-Related Di | 1981 |
Methylphenidate treatment of poststroke depression in a patient with global aphasia.
Topics: Aged; Aphasia; Cerebrovascular Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Dru | 1994 |
Use of methylphenidate in a case of mild, inoperative, idiopathic, normal pressure hydrocephalus.
Topics: Aged; Atrophy; Cerebral Cortex; Cerebral Ventricles; Depressive Disorder; Diagnosis, Differential; D | 1994 |
Successful methylphenidate treatment of apathy after subcortical infarcts.
Topics: Activities of Daily Living; Adult; Central Nervous System Stimulants; Cerebral Infarction; Frontal L | 1995 |
Precipitation of psychosis during electroshock therapy.
Topics: Adult; Chlorpromazine; Depression; Diagnosis, Differential; Drug Therapy, Combination; Electroconvul | 1975 |
Long-term methylphenidate use in the medically ill patient with organic mood syndrome.
Topics: Adult; Colonic Neoplasms; Depressive Disorder; Humans; Hypoxia, Brain; Long-Term Care; Male; Methylp | 1990 |
Cognitive impairment due to AIDS-related complex and its response to psychostimulants.
Topics: Adult; AIDS-Related Complex; Central Nervous System Stimulants; Cognition Disorders; Dextroamphetami | 1988 |
Activation, arousal, and neuropsychological rehabilitation.
Topics: Adult; Afferent Pathways; Arousal; Attention Deficit Disorder with Hyperactivity; Cerebral Cortex; C | 1987 |
Psychostimulant treatment of depressive disorders secondary to medical illness.
Topics: Adjustment Disorders; Adult; Aged; Dementia; Depression; Depressive Disorder; Dextroamphetamine; Fem | 1986 |
Iatrogenic dyskinesia. A unique reaction to parenteral methylphenidate.
Topics: Adult; Humans; Iatrogenic Disease; Injections, Intravenous; Male; Methylphenidate; Movement Disorder | 1974 |
Psychometric tests in evaluation of brain pathology, response to drugs.
Topics: Adult; Aged; Association; Attention; Behavior; Brain Damage, Chronic; Humans; Meprobamate; Methylphe | 1970 |